Clinical Effectiveness of Boxing Training in Individuals With Elevated Blood Pressure or Stage 1 Hypertension
Status
Conditions
Treatments
Details and patient eligibility
About
The goal of this clinical trial is to determine whether boxing training reduces cardiovascular risk in elevated blood pressure or hypertension stage 1 individuals.
The main questions it aims to answer are (1) if boxing training reduces peripheral and central blood pressure and (2) if boxing training improves cardiovascular function in elevated blood pressure or hypertension stage 1 individuals.
Participants with elevated blood pressure or hypertension stage 1 will be randomly divided into a control group or an intervention group. The latter group will be involved in boxing training, 3 days per week for 6 weeks.
Researchers will compare clinical and cardiovascular outcomes between the control and the intervention group.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- ≥18 years old.
- Systolic blood pressure between 120-139 mmHg and/or diastolic blood pressure between 80-89 mmHg obtained from 2 different days.
- an estimated 10-year risk of CVD ≤10%, calculated by the ACC/AHA Pooled Cohort Equations.
- no current participation in 3 or more days per week of endurance or resistance exercise training.
Exclusion criteria
- non-controlled cardiac, pulmonary, or metabolic diseases.
- smoking, consumption of nutritional supplements containing antioxidants.
- any physical impairment to exercise.
Trial design
Primary purpose
Allocation
Interventional model
Masking
24 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal